Invention Grant
- Patent Title: Multispecific antibodies that target HIV GP120 and CD3
-
Application No.: US16014153Application Date: 2018-06-21
-
Publication No.: US10882907B2Publication Date: 2021-01-05
- Inventor: Doug Rehder , Matthew R. Schenauer , Heather Stephenson , Nathan D. Thomsen
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07K16/10
- IPC: C07K16/10 ; C07K16/28 ; A61K47/68 ; A61P31/18 ; A61K51/10 ; A61K39/00
Abstract:
Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.
Public/Granted literature
- US20180371086A1 MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3 Public/Granted day:2018-12-27
Information query
